# Edarbi

NDC: 60631-080
Generic name: Azilsartan kamedoxomil
Labeler / Manufacturer: Azurity Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20130201

FDA application: NDA200796

## Active ingredients

- AZILSARTAN KAMEDOXOMIL: 80 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60631-080"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60631-080
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=52b27c75-9f5a-4816-bafd-dace9d7d2063